MedPath

Vegetables Intake and Polymorphism TAS2R38 Gene by Healthy Adults

Not Applicable
Completed
Conditions
Healthy Lifestyle
Taste Disorders
Diet Habit
Interventions
Behavioral: Control Group 2 general nutritional recommendations
Behavioral: Intervention genotype personalized nutritional recommendations
Behavioral: Control Group 1 personalized nutritional recommendations
Registration Number
NCT04145453
Lead Sponsor
Poznan University of Life Sciences
Brief Summary

Personalized nutrition is one of the most up to date trends in human nutrition and gains much interest of general public and scientists as well. Although we have gained some knowledge on gene-trait associations, the real effectiveness and usefulness of genotype-based nutritional recommendations is unknown. Many personalized nutrition companies are on the market today, some of them use personalized nutrition based on genotype analysis. For this reason, scientific basis of this approach should be clarified.

Our project can thus increase knowledge which can be applied in dietary counseling practice. Although we focus on increase vegetable and fruits intake, the study is designed as a proof of concept.

Detailed Description

In humans, the TAS2R38 receptor gene is responsible for differences in the perception of bitter taste. This gene codes for a G protein that is associated with a flavor receptor regulated by phenylthiocarbamide (PTC) and propylthiouracil (PROP) ligands, which by binding to the receptor determines the degree of bitter taste. Cruciferous vegetables contain glucosinolates and isothiocyanates, which resemble PTC and PROP and thereby affect their perception of bitter taste through the TAS2R38 regulated receptor.

The polymorphism of this gene allows to distinguish three phenotypes:

* insensitive to bitter taste \[bitter-non tasters\]

* moderately sensitive to bitter taste \[intermediate-bitter tasters\]

* sensitive to bitter taste \[bitter taster\] Previous studies have shown that people who are carriers of one PAV haplotype experience a bitter taste more than AVI / AVI homozygotes, which are less sensitive to bitter taste. Hence, the TAS2R38 gene polymorphism is associated with nutritional decisions, including choice of vegetables and coffee.

Aim of the study is to verify effectiveness of the genotype based dietary intervention in people with or without polymorphism of TAS2R38 gene.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
174
Inclusion Criteria
  • healthy
Exclusion Criteria
  • injuries, chronic diseases (e.g. diabetes, metabolic syndrome, cancer, hyperthyroidism), recent diet, pregnancy, breastfeeding, limited communication to the extent that no nutritional history can be carried out, eating disorders (according to nutritional history)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Control group 2Control Group 2 general nutritional recommendationsParticipants with AVI haplotype will receive general recommendations regarding consumption of fruit and vegetables.
intervention groupIntervention genotype personalized nutritional recommendationsParticipants with PAV haplotype will receive personalised dietary recommendations regarding consumption of fruit and vegetables. The information about genotype will be given at the beginning of study.
control group 1Control Group 1 personalized nutritional recommendationsParticipants with PAV haplotype will receive personalised dietary recommendations regarding consumption of fruit and vegetables, but the information about genotype will be given at the end of study.
Primary Outcome Measures
NameTimeMethod
TAS2R38 polymorphismbaseline

genotyping of polymorphism TAS2R38 gene (rsr713598, rs1726866, and rs10246939)

Vegetables intakeBaseline, 20 weeks

Change in frequency of vegatables intake within the group and between the groups; Block vegetables intake screener

Secondary Outcome Measures
NameTimeMethod
Fat Mass (FM) %Baseline, 20 weeks

change in Fat Mass % within the group and between the groups

Fat free mass (FFM)Baseline, 20 weeks

change in FFM (kg) within the group and between the groups

aspartate aminotransferase (ASPAT)Baseline, 20 weeks

Changes in ASPAT (U/l) within the group and between the groups

Waist circumference (WC)Baseline, 20 weeks

Change in WC (cm) within the group and between the groups

Triglycerides (TG)Baseline, 20 week

Changes in TG (mg/dl) within groups and between groups

HDL Cholesterol (HDL-Chol)Baseline, 20 weeks

Changes in HDL-Chol (mg/dl) within the group and between the groups

Insulin (INS)Baseline, 20 weeks

Changes in INS (ulU/ml) within the group and between the groups

Body Mass (BM)Baseline, 20 weeks

change in body mass (kg) within the group and between the groups

Total Cholesterol (TChol)Baseline, 20 weeks

Changes in TChol (mg/dl) within the group and between the groups

LDL Cholesterol(LDL-Chol)Baseline, 20 weeks

Changes in LDL-Chol (mg/dl) within the group and between the groups

Glucose (GLU)Baseline, 20 weeks

Changes in GLU (mg/dl) within the group and between the groups

Alanine transaminase (ALAT)Baseline, 20 weeks

Changes in ALAT (U/l) within the group and between the groups

Trial Locations

Locations (1)

Poznan University of Life Sciences

🇵🇱

Poznań, Poland

© Copyright 2025. All Rights Reserved by MedPath